Silk Road Medical Past Earnings Performance

Past criteria checks 0/6

Silk Road Medical's earnings have been declining at an average annual rate of -2.2%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 27% per year.

Key information

-2.2%

Earnings growth rate

70.4%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate27.0%
Return on equity-36.3%
Net Margin-28.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Silk Road Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:2OW Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24185-5315242
31 Dec 23177-5614541
30 Sep 23170-5513840
30 Jun 23163-5313139
31 Mar 23151-5512339
31 Dec 22139-5511636
30 Sep 22127-5711135
30 Jun 22114-6110833
31 Mar 22107-5610230
31 Dec 21101-509627
30 Sep 2194-529030
30 Jun 2190-488427
31 Mar 2178-487724
31 Dec 2075-477621
30 Sep 2073-397314
30 Jun 2070-377113
31 Mar 2070-386913
31 Dec 1963-526312
30 Sep 1956-605712
30 Jun 1949-614912
31 Mar 1942-564211
31 Dec 1835-383510
31 Dec 1714-19207

Quality Earnings: 2OW is currently unprofitable.

Growing Profit Margin: 2OW is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2OW is unprofitable, and losses have increased over the past 5 years at a rate of 2.2% per year.

Accelerating Growth: Unable to compare 2OW's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2OW is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.8%).


Return on Equity

High ROE: 2OW has a negative Return on Equity (-36.27%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.